CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed
Drug / intervention
external beam radiotherapyprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00144079
NCT00144079Phase 3Completed
CompareCT.gov

Phase 3 Trial of Adjuvant External Beam Radiotherapy for Locally Invasive Differentiated Thyroid Carcinoma

University Hospital Muenster·interventional·Posted Sep 2, 2005·Updated May 9, 2006

In Brief

A Phase 3 clinical trial evaluating external beam radiotherapy for Thyroid Neoplasms. Completed, across 10 sites in 3 countries.

Detailed Summary

The trial examines the clinical benefit of adjuvant external beam radiotherapy (RTx) for locally invasive differentiated carcinoma (TNM stages pT4 pN0/1/x M0/x; 5th ed. 1997) of the thyroid gland (DTC). Patients are treated with surgery (thyroidectomy and lymphadenectomy), radioiodine therapy (RIT) to ablate the thyroid remnant tissue, and TSH-suppressive L-thyroxine therapy with or without RTx after documented elimination of cervical I-131 uptake.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsThyroid Neoplasms
CountriesAustria, Germany, Switzerland
CollaboratorsDeutsche Krebshilfe e.V., Bonn (Germany)

Timeline

Phase 3CompletedFinished
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 2, 2005
Enrollment StartJan 1, 2000
Study CompletionJan 1, 2010
TodayJul 2, 2026
Posted 20.8 years ago

Interventions

external beam radiotherapyprocedure